-
1
-
-
0036336136
-
Design, synthesis and bioactivities of novel diarylthiophenes: Inhibitors of tumor necrosis factor-α (TNF-α) production
-
F. Masakazu, H. Tetsuya, and I. Naoko Design, synthesis and bioactivities of novel diarylthiophenes: inhibitors of tumor necrosis factor-α (TNF-α) production Bioorg. Med. Chem. 10 2002 3113 3122
-
(2002)
Bioorg. Med. Chem.
, vol.10
, pp. 3113-3122
-
-
Masakazu, F.1
Tetsuya, H.2
Naoko, I.3
-
2
-
-
37349006913
-
TNF-α and adipocyte biology
-
P.C. William, and K.S. Jaswinder TNF-α and adipocyte biology FEBS Lett. 582 2008 117 131
-
(2008)
FEBS Lett.
, vol.582
, pp. 117-131
-
-
William, P.C.1
Jaswinder, K.S.2
-
3
-
-
0032925340
-
Mechanisms of TNF-alpha-induced insulin resistance
-
G.S. Hotamisligil Mechanisms of TNF-alpha-induced insulin resistance Exp. Clin. Endocrinol. Diabetes 107 1999 119 125
-
(1999)
Exp. Clin. Endocrinol. Diabetes
, vol.107
, pp. 119-125
-
-
Hotamisligil, G.S.1
-
4
-
-
0036212593
-
Exclusive action of transmembrane TNF-α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance
-
H. Xu, J. Hirosumi, K.T. Uysal, A.D. Guler, and G.S. Hotamisligil Exclusive action of transmembrane TNF-α in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance Endocrinology 143 2002 1502 1511
-
(2002)
Endocrinology
, vol.143
, pp. 1502-1511
-
-
Xu, H.1
Hirosumi, J.2
Uysal, K.T.3
Guler, A.D.4
Hotamisligil, G.S.5
-
5
-
-
0030756346
-
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
-
K.T. Uysal, S.M. Wiesbrock, M.W. Marino, and G.S. Hotamisligil Protection from obesity-induced insulin resistance in mice lacking TNF-α function Nature 389 1997 610 614
-
(1997)
Nature
, vol.389
, pp. 610-614
-
-
Uysal, K.T.1
Wiesbrock, S.M.2
Marino, M.W.3
Hotamisligil, G.S.4
-
6
-
-
0031757099
-
Functional analysis of tumor necrosisfactor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity
-
K.T. Uysal, S.M. Wiesbrock, and G.S. Hotamisligil Functional analysis of tumor necrosisfactor (TNF) receptors in TNF-α-mediated insulin resistance in genetic obesity Endocrinology 139 1998 4832 4838
-
(1998)
Endocrinology
, vol.139
, pp. 4832-4838
-
-
Uysal, K.T.1
Wiesbrock, S.M.2
Hotamisligil, G.S.3
-
7
-
-
0032882081
-
Altered insulin secretion associated with reduced lipolytic efficiency in ap2 -/- mice
-
L. Scheja, L. Makowski, K.T. Uysal, S.M. Wiesbrock, D.R. Shimshek, D.S. Meyers, M. Morgan, R.A. Parker, and G.S. Hotamisligil Altered insulin secretion associated with reduced lipolytic efficiency in ap2 -/- mice Diabetes 48 1999 1987 1994
-
(1999)
Diabetes
, vol.48
, pp. 1987-1994
-
-
Scheja, L.1
Makowski, L.2
Uysal, K.T.3
Wiesbrock, S.M.4
Shimshek, D.R.5
Meyers, D.S.6
Morgan, M.7
Parker, R.A.8
Hotamisligil, G.S.9
-
8
-
-
16844379483
-
The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity
-
L. Makowski, K.C. Brittingham, J.M. Reynolds, J. Suttles, and G.S. Hotamisligil The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity J. Biol. Chem. 280 2005 12888 12895
-
(2005)
J. Biol. Chem.
, vol.280
, pp. 12888-12895
-
-
Makowski, L.1
Brittingham, K.C.2
Reynolds, J.M.3
Suttles, J.4
Hotamisligil, G.S.5
-
9
-
-
0029847504
-
Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein
-
G.S. Hotamisligil, R.S. Johnson, R.J. Distel, R. Ellis, V.E. Papaioannou, and B.M. Spiegelman Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein Science 274 1996 1377 1379
-
(1996)
Science
, vol.274
, pp. 1377-1379
-
-
Hotamisligil, G.S.1
Johnson, R.S.2
Distel, R.J.3
Ellis, R.4
Papaioannou, V.E.5
Spiegelman, B.M.6
-
10
-
-
34250904186
-
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
-
M. Furuhashi, G. Tuncman, C.Z. Görgün, L. Makowski, G. Atsumi, E. Vaillancourt, K. Kono, V.R. Babaev, S. Fazio, M.F. Linton, R. Sulsky, J.A. Robl, R.A. Parker, and G.S. Hotamisligil Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 Nature 447 2007 959 965
-
(2007)
Nature
, vol.447
, pp. 959-965
-
-
Furuhashi, M.1
Tuncman, G.2
Görgün, C.Z.3
Makowski, L.4
Atsumi, G.5
Vaillancourt, E.6
Kono, K.7
Babaev, V.R.8
Fazio, S.9
Linton, M.F.10
Sulsky, R.11
Robl, J.A.12
Parker, R.A.13
Hotamisligil, G.S.14
-
11
-
-
70349649220
-
Identification and characterization of a small molecule inhibitor of fatty acid binding proteins
-
A.V. Hertzel, K. Hellberg, J.M. Reynolds, A.C. Kruse, B.E. Juhlmann, A.J. Smith, M.A. Sanders, D.H. Ohlendorf, J. Suttles, and D.A. Bernlohr Identification and characterization of a small molecule inhibitor of fatty acid binding proteins J. Med. Chem. 52 2009 6024 6031
-
(2009)
J. Med. Chem.
, vol.52
, pp. 6024-6031
-
-
Hertzel, A.V.1
Hellberg, K.2
Reynolds, J.M.3
Kruse, A.C.4
Juhlmann, B.E.5
Smith, A.J.6
Sanders, M.A.7
Ohlendorf, D.H.8
Suttles, J.9
Bernlohr, D.A.10
-
12
-
-
3843057021
-
Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target
-
L. Fredik, H. Saba, A. Eva, M. Carmen, U. Jonas, S. Stefan, L. Thomas, R. Lena, and B. Tjeerd Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target Bioorg. Med. Chem. Lett. 14 2004 4445 4448
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 4445-4448
-
-
Fredik, L.1
Saba, H.2
Eva, A.3
Carmen, M.4
Jonas, U.5
Stefan, S.6
Thomas, L.7
Lena, R.8
Tjeerd, B.9
-
13
-
-
5344244051
-
New N-pyridinyl(methyl)-indolalkanamides acting as topical inammation inhibitors
-
D. Alexandra, B. Anne, E. Johan, D. Muriel, L.B. Guillaume, G. Nicole, and P. Jean-Yves New N-pyridinyl(methyl)-indolalkanamides acting as topical inammation inhibitors Bioorg. Med. Chem. Lett. 14 2004 5441 5444
-
(2004)
Bioorg. Med. Chem. Lett.
, vol.14
, pp. 5441-5444
-
-
Alexandra, D.1
Anne, B.2
Johan, E.3
Muriel, D.4
Guillaume, L.B.5
Nicole, G.6
Jean-Yves, P.7
-
14
-
-
0028135629
-
Synthesis and antiflammatory activity of indolylacrylic and methylacrylic acids
-
A. Andreanil, M. Rambaldil, A. Locatellil, and G. Pifferi Synthesis and antiflammatory activity of indolylacrylic and methylacrylic acids Eur. J. Med. Chem. 29 1994 903 906
-
(1994)
Eur. J. Med. Chem.
, vol.29
, pp. 903-906
-
-
Andreanil, A.1
Rambaldil, M.2
Locatellil, A.3
Pifferi, G.4
-
15
-
-
84860323053
-
Synthesis of p methoxy bromoacetophenone by substituting cupric bromide for liquid bromine
-
S. PengAn, and W. Binli Synthesis of p methoxy bromoacetophenone by substituting cupric bromide for liquid bromine Liaoning Chem. Ind. 32 2003 17 18
-
(2003)
Liaoning Chem. Ind.
, vol.32
, pp. 17-18
-
-
Pengan, S.1
Binli, W.2
-
16
-
-
0026069855
-
Synthesis and analgesic activity of 1-(N-methylanilinoethyl)indoles
-
A. Andreani, M. Rambaldi, A. Locatelli, F. Andreani, R. Bossa, I. Galatulas, and M. Ninci Synthesis and analgesic activity of 1-(N- methylanilinoethyl)indoles Eur. J. Med. Chem. 3 1991 125 129
-
(1991)
Eur. J. Med. Chem.
, vol.3
, pp. 125-129
-
-
Andreani, A.1
Rambaldi, M.2
Locatelli, A.3
Andreani, F.4
Bossa, R.5
Galatulas, I.6
Ninci, M.7
-
17
-
-
74549174782
-
Design, synthesis and evaluation of 3-(imidazol-1-ylmethyl) indoles as antileishmanial agents
-
G. Francis, L. Cedric, P. Fabrice, C. Damien, B. Sophie, P. Carine, L.P. Patrice, and L.B. Marc Design, synthesis and evaluation of 3-(imidazol-1- ylmethyl) indoles as antileishmanial agents J. Enzym. Inhib. Med. Chem. 24 2009 1067 1075
-
(2009)
J. Enzym. Inhib. Med. Chem.
, vol.24
, pp. 1067-1075
-
-
Francis, G.1
Cedric, L.2
Fabrice, P.3
Damien, C.4
Sophie, B.5
Carine, P.6
Patrice, L.P.7
Marc, L.B.8
-
18
-
-
0033954256
-
The protein data bank
-
H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne The protein data bank Nucleic Acids Res. 28 2000 235 242
-
(2000)
Nucleic Acids Res.
, vol.28
, pp. 235-242
-
-
Berman, H.M.1
Westbrook, J.2
Feng, Z.3
Gilliland, G.4
Bhat, T.N.5
Weissig, H.6
Shindyalov, I.N.7
Bourne, P.E.8
-
19
-
-
34548515270
-
Structural basis for activation of fatty acid-binding protein 4
-
R.E. Gillilan, S.D. Ayers, and N. Noy Structural basis for activation of fatty acid-binding protein 4 J. Mol. Biol. 372 2007 1246 1260
-
(2007)
J. Mol. Biol.
, vol.372
, pp. 1246-1260
-
-
Gillilan, R.E.1
Ayers, S.D.2
Noy, N.3
-
20
-
-
0001041959
-
Fast, efficient generation of high-quality atomic charges. AM1-BCC HF: I. Method
-
A. Jakalian, B.L.Bush, D.B. Jack, and C.I. Bayly Fast, efficient generation of high-quality atomic charges. AM1-BCC HF: I. Method J. Comput. Chem. 21 2000 132 146
-
(2000)
J. Comput. Chem.
, vol.21
, pp. 132-146
-
-
Jakalian, A.1
Bush, B.L.2
Jack, D.B.3
Bayly, C.I.4
-
21
-
-
0036890178
-
Fast, efficient generation of high-quality atomic charges. AM1-BCC HF: II. Parameterization and validation
-
A. Jakalian, D.B. Jack, and C.I. Bayly Fast, efficient generation of high-quality atomic charges. AM1-BCC HF: II. Parameterization and validation J. Comput. Chem. 23 2002 1623 1641
-
(2002)
J. Comput. Chem.
, vol.23
, pp. 1623-1641
-
-
Jakalian, A.1
Jack, D.B.2
Bayly, C.I.3
-
22
-
-
0037571112
-
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
-
T.A. Halgren Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 J. Comput. Chem. 17 1996 490 519
-
(1996)
J. Comput. Chem.
, vol.17
, pp. 490-519
-
-
Halgren, T.A.1
|